vs
Apellis Pharmaceuticals, Inc.（APLS）与GULFPORT ENERGY CORP（GPOR）财务数据对比。点击上方公司名可切换其他公司
GULFPORT ENERGY CORP的季度营收约是Apellis Pharmaceuticals, Inc.的2.0倍（$398.2M vs $199.9M），GULFPORT ENERGY CORP净利率更高（33.3% vs -29.5%，领先62.7%），GULFPORT ENERGY CORP同比增速更快（66.0% vs -5.9%），过去两年GULFPORT ENERGY CORP的营收复合增速更高（18.6% vs 7.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
Gulfport Energy Corp是一家总部位于美国的独立油气勘探生产企业，核心运营区域覆盖俄亥俄州尤蒂卡页岩区、俄克拉荷马州SCOOP产区，主要生产天然气、原油及天然气液，供应北美工业、公用事业及商业终端市场。
APLS vs GPOR — 直观对比
营收规模更大
GPOR
是对方的2.0倍
$199.9M
营收增速更快
GPOR
高出71.9%
-5.9%
净利率更高
GPOR
高出62.7%
-29.5%
两年增速更快
GPOR
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $398.2M |
| 净利润 | $-59.0M | $132.4M |
| 毛利率 | — | 76.6% |
| 营业利润率 | -25.6% | 44.9% |
| 净利率 | -29.5% | 33.3% |
| 营收同比 | -5.9% | 66.0% |
| 净利润同比 | -62.2% | 148.5% |
| 每股收益（稀释后） | $-0.40 | $7.98 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSGPOR
| Q4 25 | $199.9M | $398.2M | ||
| Q3 25 | $458.6M | $379.7M | ||
| Q2 25 | $178.5M | $447.6M | ||
| Q1 25 | $166.8M | $197.0M | ||
| Q4 24 | $212.5M | $239.9M | ||
| Q3 24 | $196.8M | $253.9M | ||
| Q2 24 | $199.7M | $181.1M | ||
| Q1 24 | $172.3M | $283.2M |
净利润APLSGPOR
| Q4 25 | $-59.0M | $132.4M | ||
| Q3 25 | $215.7M | $111.4M | ||
| Q2 25 | $-42.2M | $184.5M | ||
| Q1 25 | $-92.2M | $-464.0K | ||
| Q4 24 | $-36.4M | $-273.2M | ||
| Q3 24 | $-57.4M | $-14.0M | ||
| Q2 24 | $-37.7M | $-26.2M | ||
| Q1 24 | $-66.4M | $52.0M |
毛利率APLSGPOR
| Q4 25 | — | 76.6% | ||
| Q3 25 | — | 74.6% | ||
| Q2 25 | — | 80.7% | ||
| Q1 25 | — | 57.9% | ||
| Q4 24 | — | 63.2% | ||
| Q3 24 | — | 64.6% | ||
| Q2 24 | — | 52.2% | ||
| Q1 24 | — | 69.4% |
营业利润率APLSGPOR
| Q4 25 | -25.6% | 44.9% | ||
| Q3 25 | 48.7% | 41.9% | ||
| Q2 25 | -18.6% | 56.0% | ||
| Q1 25 | -50.0% | 6.1% | ||
| Q4 24 | -12.3% | -131.3% | ||
| Q3 24 | -24.0% | 5.7% | ||
| Q2 24 | -14.7% | -10.0% | ||
| Q1 24 | -36.0% | 28.9% |
净利率APLSGPOR
| Q4 25 | -29.5% | 33.3% | ||
| Q3 25 | 47.0% | 29.3% | ||
| Q2 25 | -23.6% | 41.2% | ||
| Q1 25 | -55.3% | -0.2% | ||
| Q4 24 | -17.1% | -113.9% | ||
| Q3 24 | -29.2% | -5.5% | ||
| Q2 24 | -18.9% | -14.5% | ||
| Q1 24 | -38.5% | 18.4% |
每股收益（稀释后）APLSGPOR
| Q4 25 | $-0.40 | $7.98 | ||
| Q3 25 | $1.67 | $4.45 | ||
| Q2 25 | $-0.33 | $9.12 | ||
| Q1 25 | $-0.74 | $-0.07 | ||
| Q4 24 | $-0.30 | $-14.72 | ||
| Q3 24 | $-0.46 | $-0.83 | ||
| Q2 24 | $-0.30 | $-1.51 | ||
| Q1 24 | $-0.54 | $2.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $1.8M |
| 总债务越低越好 | — | $788.2M |
| 股东权益账面价值 | $370.1M | $1.8B |
| 总资产 | $1.1B | $3.0B |
| 负债/权益比越低杠杆越低 | — | 0.43× |
8季度趋势，按日历期对齐
现金及短期投资APLSGPOR
| Q4 25 | $466.2M | $1.8M | ||
| Q3 25 | $479.2M | $3.4M | ||
| Q2 25 | $370.0M | $3.8M | ||
| Q1 25 | $358.4M | $5.3M | ||
| Q4 24 | $411.3M | $1.5M | ||
| Q3 24 | $396.9M | $3.2M | ||
| Q2 24 | $360.1M | $1.2M | ||
| Q1 24 | $325.9M | $8.2M |
总债务APLSGPOR
| Q4 25 | — | $788.2M | ||
| Q3 25 | — | $691.7M | ||
| Q2 25 | — | $695.2M | ||
| Q1 25 | — | $700.4M | ||
| Q4 24 | — | $702.9M | ||
| Q3 24 | — | $694.4M | ||
| Q2 24 | — | $679.5M | ||
| Q1 24 | $93.1M | $636.4M |
股东权益APLSGPOR
| Q4 25 | $370.1M | $1.8B | ||
| Q3 25 | $401.2M | $1.8B | ||
| Q2 25 | $156.3M | $1.8B | ||
| Q1 25 | $164.2M | $1.7B | ||
| Q4 24 | $228.5M | $1.7B | ||
| Q3 24 | $237.1M | $2.1B | ||
| Q2 24 | $264.3M | $2.1B | ||
| Q1 24 | $266.7M | $2.2B |
总资产APLSGPOR
| Q4 25 | $1.1B | $3.0B | ||
| Q3 25 | $1.1B | $2.9B | ||
| Q2 25 | $821.4M | $3.0B | ||
| Q1 25 | $807.3M | $2.9B | ||
| Q4 24 | $885.1M | $2.9B | ||
| Q3 24 | $901.9M | $3.2B | ||
| Q2 24 | $904.5M | $3.2B | ||
| Q1 24 | $831.9M | $3.3B |
负债/权益比APLSGPOR
| Q4 25 | — | 0.43× | ||
| Q3 25 | — | 0.38× | ||
| Q2 25 | — | 0.39× | ||
| Q1 25 | — | 0.42× | ||
| Q4 24 | — | 0.41× | ||
| Q3 24 | — | 0.34× | ||
| Q2 24 | — | 0.32× | ||
| Q1 24 | 0.35× | 0.29× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $185.4M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | — |
| 自由现金流率自由现金流/营收 | -7.1% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | 1.40× |
| 过去12个月自由现金流最近4个季度 | $45.0M | — |
8季度趋势，按日历期对齐
经营现金流APLSGPOR
| Q4 25 | $-14.2M | $185.4M | ||
| Q3 25 | $108.5M | $209.1M | ||
| Q2 25 | $4.4M | $231.4M | ||
| Q1 25 | $-53.4M | $177.3M | ||
| Q4 24 | $19.4M | $148.8M | ||
| Q3 24 | $34.1M | $189.7M | ||
| Q2 24 | $-8.3M | $123.5M | ||
| Q1 24 | $-133.0M | $188.0M |
自由现金流APLSGPOR
| Q4 25 | $-14.3M | — | ||
| Q3 25 | $108.3M | — | ||
| Q2 25 | $4.4M | — | ||
| Q1 25 | $-53.4M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-8.4M | — | ||
| Q1 24 | $-133.3M | — |
自由现金流率APLSGPOR
| Q4 25 | -7.1% | — | ||
| Q3 25 | 23.6% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | -32.0% | — | ||
| Q4 24 | 9.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -4.2% | — | ||
| Q1 24 | -77.3% | — |
资本支出强度APLSGPOR
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.2% | — |
现金转化率APLSGPOR
| Q4 25 | — | 1.40× | ||
| Q3 25 | 0.50× | 1.88× | ||
| Q2 25 | — | 1.25× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 3.61× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
GPOR
| Natural Gas Production | $296.9M | 75% |
| Other | $42.7M | 11% |
| Naturalgasliquidsales | $35.2M | 9% |
| Oil And Condensate | $23.4M | 6% |
